Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Release
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Release
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Findings May Lead to Design of New Drugs
Uncategorized

Findings May Lead to Design of New Drugs

By medwebSep 1, 2003
Share
Facebook Twitter Email

September 8, 2003

Contact: Megan Fellman at (847) 491-3115 or at
fellman@northwestern.edu

Findings May Lead to Design of New Drugs

EVANSTON, ILL.— Scientists at Northwestern University have acquired new insight into how a specialized sensor protein that acts as an early warning system detects dangerous amounts of the “coinage metals”—silver, gold, and copper—inside cells. For the first time, researchers can explain this important mechanism at the atomic level.

The findings, published September 5 in the journal Science and recently published online by the Journal of the American Chemical Society, should improve knowledge of diseases related to copper metabolism and influence the design of anticancer and antimicrobial drugs. The research may lead to better methods for removing toxic metals from the environment.

By studying the inorganic chemistry of the bacterium E. coli, a research team led by Thomas V. O’Halloran, PhD, professor of chemistry at Northwestern, established the molecular and structural basis for the cell’s early detection of miniscule amounts of copper. The work was done in collaboration with Alfonso Mondragon, PhD, professor of biochemistry, molecular biology, and cell biology at Northwestern, and James E. Penner-Hahn, PhD, professor of chemistry at the University of Michigan.

Having determined the structures of copper-, silver-, and gold-bound forms of the metalloregulatory protein CueR, the researchers were able to show the protein’s extraordinary sensitivity to copper as well as how the cell distinguishes copper from other metals, such as gold and silver.

“Metals are absolutely essential to the healthy functioning of all cells in the human body,” said Dr. O’Halloran. “But metals are high-maintenance nutrients. They are finicky and can be particularly destructive if not managed by the cell in the right way. Cells must protect themselves against excess amounts.”

Dr. O’Halloran likened the cell to a city in which metal ions are similar to important and reactive fuels that must be imported and then carefully delivered from one part of the city to another. Reactive metals such as copper have the potential to catalyze runaway reactions that could harm the cell, much as a series of explosions could damage critical systems in a city. Understanding how a cell properly deals with copper and other potentially toxic metals will aid biomedical researchers in understanding what happens when things go awry in cancer and neurodegenerative disorders, such as Wilson’s, Menkes, and Lou Gehrig’s diseases and possibly Alzheimer’s disease.

“Metals are at the center of many emerging problems in health, medicine, and the environment,” he said.

In addition to Drs. O’Halloran and Mondragon, other authors on the Science paper are Anita Changela (lead author), Kui Chen, Yi Xue, Jackie Holschen, and Caryn Outten, from Northwestern University.

Drs. O’Halloran and Penner-Hahn are joined by Chen (lead author), from Northwestern University, and Saodat Yuldasheva, from the University of Michigan, on the paper in the Journal of the American Chemical Society.

The research was supported by National Institutes of Health’s National Institute of General Medical Sciences and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Share. Facebook Twitter Email

Related Posts

Lurie Cancer Center Receives Merit Extension from NCI

Oct 20, 2021

Drug Combination May Reduce Risk of Leukemia Relapse

Mar 26, 2020

Rewriting the Role of a Transcription Factor

Mar 19, 2020

Comments are closed.

Latest News

Investigating the Connection Between Steps and Heart Disease Risk

Feb 1, 2023

Medical School Faculty Named AAAS Fellows

Jan 31, 2023

Transforming the Way Cancer Vaccines are Designed and Made

Jan 30, 2023

Calcium Channels Regulate Neuroinflammation and Neuropathic Pain 

Jan 27, 2023

Changes in Medical School Leadership

Jan 26, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
Feinberg_In_Vivo_20221209_tcrawford-24
Feinberg_In_Vivo_20221209_tcrawford-16
Feinberg_In_Vivo_20221209_tcrawford-14
Feinberg_In_Vivo_20221209_tcrawford-5
Feinberg_In_Vivo_20221209_tcrawford-6
Feinberg_In_Vivo_20221209_tcrawford-10
Feinberg_In_Vivo_20221209_tcrawford-8
Feinberg_In_Vivo_20221209_tcrawford-18
Feinberg_In_Vivo_20221209_tcrawford
Feinberg_In_Vivo_20221209_tcrawford-23
Feinberg_In_Vivo_20221209_tcrawford-25
Feinberg_In_Vivo_20221209_tcrawford-26

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.